eCommons@AKU
Department of Medicine

Department of Medicine

12-28-2020

Predictors of mortality in hospitalized patients with influenza: A
five-year experience from a tertiary care centre in Pakistan
Iffat Khanum
Amber Sabeen Ahmed
Safia Awan
Sabiha Banu
Bushra Jamil

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_med_med
Part of the Endocrinology, Diabetes, and Metabolism Commons, Infectious Disease Commons,
Influenza Humans Commons, Influenza Virus Vaccines Commons, Internal Medicine Commons,
Pulmonology Commons, and the Respiratory Tract Diseases Commons

Monaldi Archives for Chest Disease 2020; volume 90:1456

Predictors of mortality in hospitalized patients with influenza:
a five-year experience from a tertiary care centre in Pakistan
Iffat Khanum, Amber Sabeen Ahmed, Safia Awan, Sabiha Bano, Bushra Jamil

Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan

om

Key words: Influenza; mortality; predictors.

Author’s contributions: All authors contributed equally.

-c

Conflict of interest: The authors declare no conflict of interest.

N

on

Conference presentation: MMIDSP annual conference 2020; Accepted
oral presentation Gulf Chest Conference (postponed due to COVID
pandemic).
Funding: None.

Ethics approval: The study is approved by the Ethical Review
Committee of Aga Khan University Hospital.

Informed consent: Not applicable.

Received for publication: 13 June 2020.
Accepted for publication: 3 August 2020.

©Copyright: the Author(s), 2020
Licensee PAGEPress, Italy
Monaldi Archives for Chest Disease 2020; 90:1456
doi: 10.4081/monaldi.2020.1456

This article is distributed under the terms of the Creative Commons
Attribution Noncommercial License (by-nc 4.0) which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.

[page 692]

ly

on

e

us

Influenza, commonly known as flu is an infection caused by
influenza virus which is an RNA virus belonging to
Orthomyxoviridae family [1]. Most of the epidemic of influenza is
usually caused by two types of viruses, influenza A and influenza
B. Influenza A is further subcategorized into subtypes e.g.,
influenza A (H1N1) viruses, influenza A (H3N2) viruses based on
characteristics of two surface antigens, hemagglutinin (HA) and
neuraminidase (NA) [2]. The spectrum of disease from influenza
virus ranges from mild flu like illness to acute respiratory distress
syndrome (ARDS). Annual epidemics caused by influenza virus
are not only a major burden to health care resources, but also associated with high mortality rates [3]. Globally, 3-5 million cases of
influenza are reported per annum and the estimated global mortality rate is between 291,243-645,832 per year [4]. During 20172018 influenza season the overall influenza related mortality in
Europe was estimated to be 25.4 (95% CI 25.0-25.8) per 100,000
population [5].
The burden of disease in Asia is much higher than Europe.
Eleven thousand seven hundred thirty-four (11,734) laboratoryconfirmed influenza cases were reported in 19 Asian countries
between 2010-2017 [6]. In 2015, about more than 30,000 cases
and 1731 deaths were reported in India alone [7]. In a laboratorybased influenza surveillance study conducted between 2007 and
2017 a total of 3475 influenza cases were detected in Pakistan. In
2017, influenza related death from Pakistan was reported to be 2.0
per 100,000 [8,9]. Despite the annual epidemics of influenza in
Pakistan there have been very few studies done on the disease
from our country. To be better prepared to handle influenza epidemics and to decrease the mortality rates associated with the disease, it is of paramount importance to know the predictors of mortality of influenza. Respiratory failure is the major cause of mortality in patient with influenza infection [10]. A study from India,
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Influenza outbreaks are associated with significant morbidity.
Our aim was to determine the factors associated with increased
mortality in hospitalized patients admitted with diagnosis of
influenza, at a tertiary care center in Pakistan. This study included
all adult patients with an influenza infection, confirmed by realtime reverse-transcriptase polymerase-chain-reaction (RT-PCR) at
Aga Khan University Hospital Pakistan. In our study, 112 patients
with laboratory-confirmed influenza virus infection were admitted
at our hospital from the 1st of January 2013 to the 31st of
December 2018. Eighty-nine patients (79.46%) were managed in
ward or special care units and 23 patients (20.5%) received treatment in intensive care unit (ICU). The overall mortality in our
study was 15/112 (13.4%) with the mortality rate of ICU patients

being 47.8% while the mortality rate of patients treated in special
care units and wards was only 4.5%. The mean age of patients
with influenza infection was 58.1 years (±16.6). Influenza virus
type A was found in 87 patients (77.6%), while influenza type B
was present in only 25 (22.4%) patients. Out of the 15 non-survivors, 14 had influenza A. Only 17 patients (15.2%) were found
to have positive culture of respiratory specimen, out of which 3
were non-survivors and 14 were survivors. Our analysis identified
septic shock (odds ratio 45.24; 95%, confidence interval 6.20-330;
p<0.001), renal failure (odds ratio 10.88; 95%, confidence interval
1.61-73.52; p=0.01) and ICU stay (odds ratio 17.22; 95%, confidence interval 2.68-110.5; p=0.003) as independent risk factors
associated with in-hospital mortality.
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We conducted a retrospective cross-sectional study from
January 13-December 18, at Aga Khan University Hospital in
Pakistan which is a 750 bedded JCIA accredited tertiary care hospital. We included patients aged 18 and above, of both sexes, who
had symptoms of influenza like illness (temperature of 37.8°C or
higher along with cough or sore throat) confirmed by Real-time
Reverse-Transcriptase Polymerase Chain-reaction (RT-PCR).
Nasal swabs were taken under aseptic precautions of all patients
admitted with influenza like illness.
Clinical data was collected from review of patient’s daily
records. Radiological and laboratory data were obtained from electronic records. Data was collected regarding baseline demographics, symptoms at time of admission, oseltamivir prescription,
antibiotics, any positive cultures (blood, sputum, and urine), hospital and Intensive Care Unit (ICU) length of stay. All the interventions undertaken like invasive and non-invasive ventilation, renal
replacement therapy, use of vasopressors, and cases of septic shock
were recorded. Data was also obtained for the oxygen requirements, development of ARDS and use of steroids. Data regarding
development of complications and clinical outcome at discharge
was also collected. Ethical review committee of Aga Khan
Hospital had approved the study.
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aged in ward or special care units and 23 patients (20.5%) received
treatment in ICU. Although the overall mortality in our study was
13.4%, the mortality rate of patients admitted in ICU with influenza was 47.8%. The mean age of patients with influenza infection
was 58.1 years (±16.6). The majority of patients (42% of the total
number) were between 60 and 75 years of age but the 40-60 years
age group was found to have the highest mortality rate (23.33%).
Even though 62.5% (70/112) of all patients were female, male
patients had higher mortality (19.02%v/s 10%). Fourteen patients
were pregnant and all but one of them survived.
A total of 72 out of 112 patients (64.2%) had at least one co
morbid illness. Hypertension (n=54, 48.2%) and Diabetes (n=51,
45.5 %) were two most common comorbid conditions in our study
population. Other co-morbid observed were, chronic lung diseases
(n=32, 28.6%), heart disease (n=18, 16.1%) and renal impairment
(n=12, 10.71%), while neurological diseases were present in only
4 patients (3.5%) (Figure 1). Among all co-morbid conditions,
heart diseases were the only one which were more prevalent in
non-survivors (4/15, 26.7%) compared to survivors (14/89, 14.4%;
the results though were not statistically significant). The time
between onset of symptoms and hospital admission ranged from 125 days, with a median of 5 days. It was 5.1±2.7 days in survivors
and 7±5.2 days in non-survivors. Fever (93%) and cough (90%)
were the most common symptoms, followed by shortness of breath
(61%). The clinical presentations were equally distributed among
survivors and non-survivors. Only 20 patients (17.9%) received
invasive mechanical ventilation, out of which 10 died. Forty
patients received non-invasive ventilation.
Influenza virus type A was found to be the most common strain
of influenza in this setting. Eighty-seven patients (77.6%) were
positive for influenza type A, while influenza type B was present
in only 25 (22.4%) patients. Out of the 15 non-survivors, 14 had
influenza A.
Only 17 patients (15.2%) were found to have positive culture
of respiratory specimen, out of which 3 were non-survivors and 14
were survivors. Staphylococcus aureus was the most common isolated organism (37% of overall culture positive organism), followed by Aspergillus spp. (29% of overall culture positive organism). Among non-survivors, two patients had sputum culture positive for Acinetobacter and 1 had positive sputum culture for H.
influenzae. All patients received oseltamivir and the mean duration
between the onset of symptoms and the initiation of therapy was

us

during influenza outbreak of 2015 showed that the requirement of
intubation was the only significant predictor of mortality related to
the disease [11]. In a meta-analysis, which included 600,000
patients, risk factors for influenza associated mortality were age,
atrial fibrillation and pneumonia [12].
To our knowledge, there is no published five-years study from
Pakistan on predictors of influenza related mortality. The purpose
of this study is to identify factors associated with mortality in hospitalized influenza over a period of five years at tertiary care hospital in Pakistan.

N

A descriptive analysis was done for demographic and clinical
features. The results were presented as mean ± SD for quantitative
variables and numbers (percentage) for qualitative variables.
Differences in proportions, between survivors and non-survivors,
were assessed by using the Chi-square test or Fisher exact test
where appropriate. To assess univariate associations between the
outcomes and potential predictors, odds ratios (ORs) and their 95%
confidence intervals (CIs) were computed by logistic regression
analysis. All p-values were two sided and considered as statistically significant if <0.05. All significant factors on univariate analysis
were considered for inclusion in the multivariable logistic model.
All analyses were conducted by using the SPSS software,
release 16.0.

Results

In our study, 112 patients with laboratory confirmed influenza
virus infection were admitted at our hospital from 1st January 2013
to 31st December 2018. Eighty-nine patients (79.46%) were man-

Figure 1. Influenza and comorbid illnesses.
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who did not survive compared to only 6% of survivors. Difficult
management of septic shock, in the presence of worsening hypoxemia and ARDS seems to be the likely reason behind these results
[18]. This association between septic shock and influenza, though
was not directly compared in previous studies done globally but
reported in literature [19,20,22].
In our study 10/15 that is 66.66% of non-survivors had renal
failure. This appeared to be another strong predictor of influenza
mortality, as is also shown, in most of the studies done globally
[22-24]. The mortality rate was higher in middle-aged group, in
spite of the lower incidence in current study. This is consistent
with results of the previous studies, which also showed higher
mortality among middle aged group [25,26]. We need further
large-scale investigations to identify the true relationship
between age group and influenza mortality In our study, females
had lower mortality rates compared to males, even though the
majority of the influenza patients were females. Although previous literature regarding influenza related complications showed
higher mortality in male patients as compared to female, it would
be inappropriate to assume association of male gender with
increased risk of mortality due to non-availability of sufficient
epidemiological data [27,28]. Time from onset of symptoms to
hospital admission was found to be associated with increased risk
of mortality in our study. Delay in seeking medical care with
severe influenza, hence resulting in late initiation of antiviral
therapy are associated with poor outcomes [29,30]. This is also
signifying a lack of primary and secondary care facilities in our
country, where patients are instead brought to tertiary care facilities, with more severe and advance stage of disease. In present
study, only 17 patients had positive sputum culture for secondary
bacterial or fungal infection. This could be attributed to early initiation of empirical antibiotics at our institute. Staphylococcus
Aureus, as expected, was the commonest organism isolated,
which is in line with all previous reports [31,32]. Similarly, fungal infections were also found to be the second highest reported
infection, in our study. Influenzas infection is a risk factor for
invasive pulmonary aspergillosis even in immunocompetent
patients and can lead to invasive disease [33,34]. The pathogen
Aspergillus fumigatus was isolated in 5 out of 17 culture positive
patients. All patents with Aspergillus isolated in respiratory
secretion had underlying obstructive airway diseases. This finding can therefore be due to colonization of respiratory tract by the
organism, as all patients improved without any antifungal therapy. The high incidence of co-infections might be result of some
immune defect in these patients, making them more susceptible
to acquire these infections.
Our study has few limitations. It is a single centre study done
at a tertiary care university hospital. The number of cases is therefore limited, and they are also more severe in intensity as compared to cases in district hospitals. The findings observed from this
university hospital study might not be generalizable to other hospitals. The lack of disease severity scoring system like APACHE or
SOFA makes it difficult to truly ascertain the risk of mortality in
these patients. Being a retrospective study, we might have some
inadequate data. Our sample size was small, and the results
observed might change if the study is done with a larger sample
size.
Despite the above limitations, our study has shown novel findings about mortality prediction in hospitalized influenza patients
during five-years period. The mortality of influenza in our institute
was 13% but it reached a significantly high percentage of 47.2% in
severe influenza patient requiring mechanical ventilation and ICU
admissions.

-c

Discussion

om

m
er

ci

5.3±3.3 days. Delay in the initiation of oseltamivir was associated
with increased complications.
The most common influenza related complications that were
observed in our study was secondary bacterial pneumonia (65%)
followed by acute renal failure (30%). Among survivors, renal failure was present in 24/89 (26.96%) patients and among non-survivors, it was present in 10/15 (66.66%) patients. ARDS was
reported in 16/112 (14 %) of the patients, out of which 9 were nonsurvivors. Seventeen patients (15%, of total influenza patients)
were diagnosed with septic shock and it was found to be more
prevalent in non-survivors. Eleven out of fifteen (73.33%) nonsurvivors were found to have septic shock, while amongst survivors, only 6/89 (6.74%) had the complication. Cardiac complications, as a group were present in 27 patients (24.1%) among which
16 patients had acute coronary syndrome; among these patients 12
were survivors and 4 were non-survivors. Eleven patients developed arrhythmias during their hospital stay and only one of them
was a non-survivor. Steroids were given to 61 patients (54.5%), out
of which, 10 of them were non-survivors (66.66%). The average
length of a hospital stay for a non-survivor was 12.23±7.8 days,
while that of survivor was 6.53±6.1 days. The length of ICU stay
was also longer for non-survivors as compared to survivors
(10.23±6.6 days vs 7.73±5.8 days).
Univariate and multivariate logistic regression was used to
identify predictors of mortality in influenza (Table 1). The length
of hospital stays (p=0.01), prolonged duration between the onset of
illness and hospital admission (p=0.03), the length of ICU stays
(p<0.001), invasive ventilation (p<0.001), ARDS (p=0.001), respiratory failure (p=0.008), septic shock (p<0.001) and acute renal
failure (p<0.001) were considered to be significant in the univariate analysis. The multivariate analysis identified septic shock
(odds ratio 45.24; 95%. confidence interval 6.20-330; p<0.001),
renal failure (odds ratio 10.88; 95%. confidence interval 1.6173.52; p=0.01) and ICU stay (odds ratio 17.22; 95%. confidence
interval 2.68-110.5; p=0.003) as independent risk factors associated with in-hospital mortality (Table 2).
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This study reported on a series of hospitalized patients with
laboratory confirmed influenza infection, from January 2012December 2018, at a tertiary care hospital. The overall mortality
rate in our study was found to be 13.4%, which is comparable to
similar studies done globally and also from other countries in
region [12]. The ICU stay, along with the presence of septic shock
and acute renal failure, were found to be strong predictors of mortality in our hospitalised patients with influenza. In this study,
20.5% of the influenza patients received treatment in the ICU
which is found to be higher than the number reported in the literature [13,14]. As our hospital’s ICU only admits patients requiring
invasive mechanical ventilation and level 3 care, the mortality
rates are therefore indicative of severity of the disease, leading to
ARDS and the need of mechanical ventilation. The ICU mortality
rate in this study was found to be 47.8% which is higher than other
ICU mortality rates observed worldwide [14-17]. Our ICU patients
were older with average age of 66, with diabetes and hypertension
in 2/3rd of them, which might be contributing, to high mortality.
This indicates that, severe form of influenza is associated with high
mortality, compared to milder form of the disease. Septic shock in
our study was found to be a very strong predictor of mortality in
influenza patients, being present in 11 out of 15 patients (73.33%)
[page 694]
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Table 1. Predictors of mortality in influenza.
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57.9±17.6

59.5±17.6

0.72
0.17

34 (35.1)
63 (64.9)
27.3±9.0
5.1±2.7
7.7±5.8
6.5±6.1

8 (53.3)
7 (46.7)
25.0±2.9
7.0±5.2
10.2±6.6
12.2±7.8

0.35
0.03*
0.33*
0.01*

45 (46.4)
46 (47.4)
12 (12.4)
15 (15.5)
14 (14.4)
11 (11.3)
3 (3.1)
4 (4.1)
6 (6.2)
1 (1.0)
13 (13.4)

6 (40)
8 (53.3)
2 (13.3)
3 (20)
4 (26.7)
1 (6.7)
0
0
0
2 (13.3)
1 (6.7)

0.64
0.67
0.91
0.65
0.23
0.58
0.49
0.42
0.32
0.04
0.68
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14 (93.3)
5 (33.3)
3 (20.0)
0
3 (20)
1 (6.7)
1 (6.7)
10 (66.7)
2 (13.3)
0
0
4 (26.7)
6 (40.0)
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90 (92.8)
87 (89.7)
38 (39.2)
14 (14.4)
2 (2.1)
7 (7.2)
8 (8.2)
1 (1.0)
58 (59.8)
5 (5.2)
6 (6.2)
8 (8.2)
29 (29.9)
7 (7.2)
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Age (years)
Gende
Male
Female
Body mass index
Duration, illness-admission
Length of ICU stay
Length of stay
Comorbidities
Diabetes mellitus
Hypertension
Asthma
Chronic lung disease
Heart disease
Kidney disease
Liver disease
Neurology disease
Immunosuppression
Blood disease
Pregnancy
Symptoms
Fever
Cough
Sputum
Myalgia
Headache
Diarrhoea
Nausea and vomiting
Confusion
Dyspnoea
Hypotension
Muscle weakness
General weakness
Upper respiratory tract infection symptoms
Arrhythmia
Influenza type
A
B
ICU stay
Ventilation
Procalcitonin
Treatment
Steroid
TA/sputum positive
Bacterial pneumonia
Exacerbation of underlying disease
Respiratory failure
Acute respiratory distress syndrome
Pneumothorax
Pulmonary disease
Acute coronary syndrome
Arrhythmias
Sepsis/septic shock
Acute kidney injury
Cerebrovascular accident
Seizure

Survivors (n=97)

0.93
0.99
0.66
0.69
0.99
0.13
0.99
0.25
0.61
0.23
0.99
0.59
0.99
0.002

73 (75.3)
24 (24.7)
12 (12.4)
10 (10.3)
4.7±13.5

14 (93.3)
1 (6.7)
11 (73.3)
10 (66.7)
12.6±13.5

<0.001
<0.001
0.04*

51 (52.6)
14 (17.7)
56 (57.7)
14 (14.4)
19 (19.6)
9 (9.3)
3 (3.1)
13 (13.4)
11 (11.3)
7 (7.2)
6 (6.2)
23 (24)
2 (2.1)
1 (1.0)

10 (66.7)
3 (27.3)
11 (73.3)
1 (6.7)
8 (53.3)
7 (46.7)
0
1 (6.7)
5 (33.3)
1 (6.7)
11 (73.3)
11 (73.3)
0
0

0.30
0.42
0.25
0.68
0.008
0.001
0.99
0.68
0.03
0.99
<0.001
<0.001
0.99
0.99
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1.0
10.88 (1.61-73.52)

0.01

1.0
17.22 (2.68-110.54)

0.003

13.
14.
15.

Conclusions

Our study has showed that development of concomitant septic
shock and renal failure increases the odds of mortality in influenza
patients. This finding might help clinicians in more vigilant care of
these patients with earlier ICU transfers and probable use of invasive hemodynamic monitoring devices in management of these
patients.
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